Your skin can be damaged by exposure to thirdhand smoke
Scientists from the University of California Riverside found that dermal exposure to nicotine concentrations found in thirdhand smoke, or THS, and electronic cigarette spills...
Multiple heart problems may give you triple dementia risk
Scientists from Oxford University and the University of Exeter found that having multiple conditions that affect the heart is linked to a greater risk...
A single dose of new drug can prevent COVID-19 effectively
In a recent study from the University of Colorado, researchers found that a single dose of AZD7442 is effective in preventing COVID-19.
In the study,...
People with these inflammatory conditions have higher COVID-19 death risk
Scientists from the London School of Hygiene & Tropical Medicine found that people with certain inflammatory immune conditions affecting the joints, bowel and skin,...
Vascular dementia: What you need to know
Vascular dementia is caused by conditions that damage the blood vessels in the brain, depriving the brain of oxygen.
It is the second most common...
It can take 6 months to recover from heart damage after COVID-19 infection
Scientists from Appalachian State University found that arterial stiffness and blood pressure in young, otherwise healthy adults may take as long as six months...
Common native Indian medicine can effectively treat type 2 diabetes
Scientists from the University of Nottingham found that several traditional medicines commonly used in South Asia, are effective in maintaining blood sugar levels in...
Bad dreams an early warning sign of Parkinson’s disease
Scientists from the University of Birmingham found older adults who start to experience bad dreams or nightmares could be exhibiting the earliest signs of...
New COVID vaccine made of zinc and copper supplements could prevent disease
In a recent study from Tel Aviv University, researchers developed a new vaccine that contains several common dietary supplements to protect against COVID-19 as well...
This diabetes drug could help obese people lose 20% of body weight
Scientists from Yale School of Medicine found that people with obesity treated with a novel GIP/GLP-1 receptor agonist, tirzepatide, lost about 52 pounds on...